webinar register page

All fields are required

Your Information
Send to
Message preview	Hi there, You are invited to a Zoom webinar. When: May 18, 2022 06:30 PM Eastern Time (US and Canada) Topic: Multi-Disciplinary Symposium on Stroke and Ocular Ischemia Register in advance for this webinar: https://us06web.zoom.us/webinar/register/WN_LvdRy9EhTfiecMsW7Gz5pA After registering, you will receive a confirmation email containing information about joining the webinar. ---------- Webinar Speakers Leonard Messner, OD, FAAO (Moderator) (Vice President for Strategy and Institutional Advancement @Illinois College of Optometry) Stacey Keppol, OD, FAAO (Moderator) (Optometric Physician & President of PNW Chapter of AAO @Northwest Eye Surgeons) Ruth Thomson Treat, MD (Neurologist, Swedish Neuroscience Institute Telestroke Specialist, Neurohospitalist ) In this presentation, we will gain an understanding of the significance of stroke as a common cause of morbidity and mortality. We will increase awareness of common and uncommon presentations of stroke in clinical practice, the broad demographic that is at risk, and leading risk factors. To conclude, we pre-determine an action plan for managing stroke, or suspicions of stroke, when it occurs in unexpected settings. Ny-Ying Lam, MD (Assistant Professor, Department of Rehabilitation Medicine, University of Washington ) Functional recovery after stroke is enhanced by the impact of rehabilitation interventions on neuroplasticity. This talk highlights vision impairments after stroke, other common stroke-related impairments and their impact on function, reviews rehabilitation principles and prognosis for neuro recovery, and recognition of the synergistic role of the rehab and family teams. Andrew Lee, MD (Herb and Jean Lyman Centennial Chair in Ophthalmology Professor and Chair, Blanton Eye Institute, Houston, Texas ) We appreciate that acute central retinal artery occlusion (CRAO) is a neuro-ophthalmic emergency. Similar as “Time is Brain” for intracranial stroke, “Time is Retina” for CRAO. We will discuss the atherosclerotic risk factors that predispose to cardio, peripheral, and cerebrovascular disease that are present in CRAO, and must be thoroughly evaluated to prevent further medical comorbidities. And, we always rule out GCA in the diagnostic algorithm. In conclusion, we review the large, well-designed randomized controlled trials to establish the most effective treatment for acute CRAO. Steven R. Hamilton, MD (Clinical Professor of Ophthalmology and Neurology, University of Washington ) This is an up-to-date review of the clinical features distinguishing arteritic from nonarteritic Anterior ischemic optic neuropathy. Key risk factors predisposing patients to NAION with emphasis on conditions that are treatable will be discussed. A concise approach to the urgent work up and treatment for arteritic AION will be presented.

Time Zone: